GenoFocus Statistics

Total Valuation

GenoFocus has a market cap or net worth of KRW 107.32 billion. The enterprise value is 146.68 billion.

Market Cap	107.32B
Enterprise Value	146.68B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

GenoFocus has 24.01 million shares outstanding. The number of shares has increased by 1.66% in one year.

Current Share Class	n/a
Shares Outstanding	24.01M
Shares Change (YoY)	+1.66%
Shares Change (QoQ)	+0.30%
Owned by Insiders (%)	32.95%
Owned by Institutions (%)	n/a
Float	16.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.17
PB Ratio	4.51
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-51.37
EV / Sales	4.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-69.70

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.39.

Current Ratio	0.63
Quick Ratio	0.45
Debt / Equity	1.39
Debt / EBITDA	n/a
Debt / FCF	-19.51
Interest Coverage	-0.93

Financial Efficiency

Return on equity (ROE) is -1.56% and return on invested capital (ROIC) is -3.43%.

Return on Equity (ROE)	-1.56%
Return on Assets (ROA)	-3.05%
Return on Capital (ROIC)	-3.43%
Revenue Per Employee	473.49M
Profits Per Employee	-41.99M
Employee Count	68
Asset Turnover	0.33
Inventory Turnover	3.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.05%
50-Day Moving Average	3,534.40
200-Day Moving Average	3,737.08
Relative Strength Index (RSI)	55.07
Average Volume (20 Days)	1,320,502

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GenoFocus had revenue of KRW 32.20 billion and -2.86 billion in losses. Loss per share was -125.15.

Revenue	32.20B
Gross Profit	11.34B
Operating Income	-4.77B
Pretax Income	276.16M
Net Income	-2.86B
EBITDA	-198.80M
EBIT	-4.77B
Loss Per Share	-125.15

Full Income Statement

Balance Sheet

The company has 8.46 billion in cash and 41.07 billion in debt, giving a net cash position of -32.61 billion or -1,358.09 per share.

Cash & Cash Equivalents	8.46B
Total Debt	41.07B
Net Cash	-32.61B
Net Cash Per Share	-1,358.09
Equity (Book Value)	29.51B
Book Value Per Share	992.09
Working Capital	-13.06B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.13 billion and capital expenditures -971.49 million, giving a free cash flow of -2.10 billion.

Operating Cash Flow	-1.13B
Capital Expenditures	-971.49M
Free Cash Flow	-2.10B
FCF Per Share	-87.66

Full Cash Flow Statement

Margins

Gross margin is 35.21%, with operating and profit margins of -14.81% and -8.87%.

Gross Margin	35.21%
Operating Margin	-14.81%
Pretax Margin	0.86%
Profit Margin	-8.87%
EBITDA Margin	-0.62%
EBIT Margin	-14.81%
FCF Margin	-6.54%

Dividends & Yields

GenoFocus does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.66%
Shareholder Yield	-1.66%
Earnings Yield	-2.80%
FCF Yield	-1.96%

Stock Splits

The last stock split was on March 19, 2018. It was a forward split with a ratio of 2.

Last Split Date	Mar 19, 2018
Split Type	Forward
Split Ratio	2

Scores

GenoFocus has an Altman Z-Score of 0.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.37
Piotroski F-Score	n/a